Plus Therapeutics Inc (PSTV) — Cash Flow Reinvestment Rate
Latest as of December 2019:
2.75x
Plus Therapeutics Inc (PSTV) has a Cash Flow Reinvestment Rate of 2.75x as of December 2019, reinvesting $2.85 Million (capex $59.00K plus investments $2.79 Million) from operating cash flow of $1.04 Million. Check cash flow quality index of Plus Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
2.75x
(Capex + Investments) / Operating CF
Total Reinvested
$2.85 Million
Capex + Investments
Operating Cash Flow
$1.04 Million
USD
Capital Expenditures
$59.00K
USD
Annual Cash Flow Reinvestment Rate for Plus Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Plus Therapeutics Inc. For live market cap and broader valuation context, see how much is Plus Therapeutics Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow